SomaLogic, Inc. (SLGC)
NASDAQ: SLGC · IEX Real-Time Price · USD
2.73
+0.02 (0.74%)
At close: Nov 27, 2023, 4:00 PM
2.71
-0.02 (-0.73%)
After-hours: Nov 27, 2023, 5:07 PM EST
SomaLogic Revenue
SomaLogic had revenue of $81.72M in the twelve months ending September 30, 2023, down -19.75% year-over-year. Revenue in the quarter ending September 30, 2023 was $22.05M, a -47.14% decrease year-over-year. In the year 2022, SomaLogic had annual revenue of $97.67M with 19.65% growth.
Revenue (ttm)
$81.72M
Revenue Growth
-19.75%
P/S Ratio
6.28
Revenue / Employee
$181,206
Employees
451
Market Cap
513.44M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 97.67M | 16.04M | 19.65% |
Dec 31, 2021 | 81.63M | 25.74M | 46.05% |
Dec 31, 2020 | 55.89M | 23.70M | 73.64% |
Dec 31, 2019 | 32.19M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSLGC News
- 26 days ago - SomaLogic announces new SomaScan® 11K Platform - GlobeNewsWire
- 27 days ago - SomaLogic to Announce Third Quarter 2023 Financial Results on November 8, 2023 - GlobeNewsWire
- 7 weeks ago - STANDARD BIOTOOLS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Standard BioTools Inc. - LAB - Business Wire
- 7 weeks ago - LAB INVESTOR ALERT: Julie & Holleman LLP Announces Investigation of Proposed Merger Between Standard BioTools and SomaLogic - PRNewsWire
- 7 weeks ago - Shareholder Alert: Ademi LLP investigates whether SomaLogic, Inc. has obtained a Fair Price in its transaction with Standard BioTools - PRNewsWire
- 7 weeks ago - SLGC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of SomaLogic, Inc. Is Fair to Shareholders - Business Wire
- 7 weeks ago - SomaLogic's stock surges as it agrees to be bought by Standard BioTools in all-stock merger - Market Watch
- 2 months ago - SomaLogic and Korea's DNA Link partner to bring the 7,000-plex SomaScan® platform to the fast-growing Asia-Pacific proteomics market - GlobeNewsWire